Different Gene Expression Patterns of IL-1 Family Members in Parkinson's Disease: Results from Bayesian Regression Model

  • Negin Jafariaghdam Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  • Majid Khoshmirsafa Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Alireza Zamani Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  • Elahe Talebi-Ghane Modeling of noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
  • Shadi Moradi Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  • Faezeh Shahba Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Mehrdokht Mazdeh Department of Neurology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  • Mohammad Mahdi Eftekharian Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Keywords: Interleukin-1 receptor accessory protein; Interleukin-1; Interleukin-33; Interleukin-36; Parkinson disease

Abstract

Parkinson's disease, the second most prevalent neurodegenerative disorder lacking a recognized etiology, is influenced by oxidative stress and alterations in inflammatory cytokine levels. This study aimed to investigate the expression levels of Interleukin(IL)1 receptor accessory protein (IL-1RAcP), IL1β, IL1α, IL33, and IL36 genes in blood cells and serum IL-1β levels in Parkinson's disease patients compared to healthy controls (HCs).

In this case-control study, 44 Parkinson's disease patients and 44 age- and sex-matched HCs were included. Gene expression levels were assessed using Quantitative Real-time PCR, and serum IL-1β levels were measured via enzyme-linked immunosorbent assay. Advanced statistical analyses using the Bayesian regression model in R software were employed.

Parkinson's disease patients exhibited elevated expression levels of IL-1RAcP and IL1β genes  but decreased levels of IL1α, IL33, and IL36 compared to HCs. Age-based differences were not significant. Regarding gender, IL33 transcript levels were significantly higher in males, and serum IL-1β levels were increased in patients. Subgroup analysis by gender indicated alterations in IL1β and IL-1RAcP expression in both genders, while IL1α, IL33, and IL36 showed reduced expression only in males. Remarkably, only female patients displayed significantly higher serum IL-1β levels than female HCs.

These findings suggest that dysregulation of immune-related factors plays a crucial role in Parkinson's disease.

Published
2024-02-20
Section
Articles